NCT00001146View on ClinicalTrials.gov

Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

August 31, 2002

Conditions

Bipolar DisorderInvolutional DepressionMood Disorder

Interventions

DRUG

Ethyl Eicosapentaenoic Acid

DRUG

OmegaBrite

Trial Locations (1)

20892

National Institute of Mental Health (NIMH), Bethesda

All Listed Sponsors

lead

National Institute of Mental Health (NIMH)

NIH